163 related articles for article (PubMed ID: 37385671)
1. Reply: Radiopharmaceutical Extravasations CanHave Consequences.
Parihar AS; Raymond-Schmidt L; Crandall JP; Dehdashti F; Wahl RL
J Nucl Med; 2023 Aug; 64(8):1324-1325. PubMed ID: 37385671
[No Abstract] [Full Text] [Related]
2. Radiopharmaceutical Extravasations Can Have Consequences.
Bailey DL
J Nucl Med; 2023 Aug; 64(8):1324. PubMed ID: 37385674
[No Abstract] [Full Text] [Related]
3. Consequences of radiopharmaceutical extravasation and therapeutic interventions: a systematic review.
van der Pol J; Vöö S; Bucerius J; Mottaghy FM
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1234-1243. PubMed ID: 28303300
[TBL] [Abstract][Full Text] [Related]
4. [Extravasation of radiopharmaceuticals: preventive measures and management recommended by SoFRa (Société Française de Radiopharmacie)].
Barré E; Nguyen ML; Bruel D; Fournel C; Hosten B; Lao S; Vercellino L; Rizzo-Padoin N
Ann Pharm Fr; 2013 Jul; 71(4):216-24. PubMed ID: 23835019
[TBL] [Abstract][Full Text] [Related]
5. Extra-articular contrast material leaks into locations unrelated to the injection path in shoulder MR arthrography.
Ogul H; Kantarci M; Topal M; Karaca L; Tuncer K; Pirimoglu B; Okur A; Yildirim OS; Levent A
Eur Radiol; 2014 Oct; 24(10):2606-13. PubMed ID: 24962827
[TBL] [Abstract][Full Text] [Related]
6. Dexrazoxane: a management option for anthracycline extravasations.
Vidall C; Roe H; Dougherty L; Harrold K
Br J Nurs; 2013 Sep 12-25; 22(17):S6 -12. PubMed ID: 24067273
[TBL] [Abstract][Full Text] [Related]
7. Reply to "Early subcutaneous wash-out in acute extravasations", by R. Giunta (Ann Oncol 2004; 15: 1146), and to the reply by D. Schrijvers (Ann Oncol 2004; 15: 1147).
Chacon MR
Ann Oncol; 2005 Jan; 16(1):170. PubMed ID: 15678595
[No Abstract] [Full Text] [Related]
8. Extravasation of liposomal doxorubicin induces irritant reaction without vesicant injury.
Curtit E; Chaigneau L; Pauchot J; Nguyen T; Nerich V; Bazan F; Thiery-Vuillemin A; Demarchi M; Pivot X; Villanueva C
Anticancer Res; 2012 Apr; 32(4):1481-3. PubMed ID: 22493389
[TBL] [Abstract][Full Text] [Related]
9. [The administration of intravenous contrast agents: extravasations].
Tardáguila de la Fuente G; Santos Armentia ME; Tardáguila Montero F
Radiologia; 2014 Jun; 56 Suppl 1():38-44. PubMed ID: 25015555
[TBL] [Abstract][Full Text] [Related]
10. The Scientific and Clinical Case for Reviewing Diagnostic Radiopharmaceutical Extravasation Long-Standing Assumptions.
Osborne D; Lattanze R; Knowland J; Bryant TE; Barvi I; Fu Y; Kiser JW
Front Med (Lausanne); 2021; 8():684157. PubMed ID: 34262915
[No Abstract] [Full Text] [Related]
11. Monoclonal antibody extravasations: Two case reports and literature review.
Rodríguez-Alarcón A; Conde-Estévez D
J Oncol Pharm Pract; 2021 Apr; 27(3):761-763. PubMed ID: 32799778
[TBL] [Abstract][Full Text] [Related]
12. Treatment of anthracycline extravasations using dexrazoxane.
Conde-Estévez D; Mateu-de Antonio J
Clin Transl Oncol; 2014 Jan; 16(1):11-7. PubMed ID: 23949792
[TBL] [Abstract][Full Text] [Related]
13. Extravasation management.
Schulmeister L
Semin Oncol Nurs; 2007 Aug; 23(3):184-90. PubMed ID: 17693345
[TBL] [Abstract][Full Text] [Related]
14. Anthracycline extravasations: prevention and management.
Roe H
Br J Nurs; 2011 Sep 22-Oct 13; 20(17):S16, S18-22. PubMed ID: 22067533
[TBL] [Abstract][Full Text] [Related]
15. [Surgical treatment of extravasation injuries].
Goertz O; Hirsch T; Ring A; Daigeler A; Hauser J; Langer S; Steinstraesser L; Steinau HU
Zentralbl Chir; 2014 Dec; 139 Suppl 2():e103-8. PubMed ID: 21294083
[TBL] [Abstract][Full Text] [Related]
16. Extravasation of doxorubicin from vascular access devices.
Curran CF; Luce JK
Sel Cancer Ther; 1990; 6(2):103-7. PubMed ID: 2367752
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric consequences of interstitial extravasation following i.v. administration of a radiopharmaceutical.
Shapiro B; Pillay M; Cox PH
Eur J Nucl Med; 1987; 12(10):522-3. PubMed ID: 3569341
[TBL] [Abstract][Full Text] [Related]
18. Radiopharmaceutical extravasation in bone scintigraphy: a cross-sectional study.
Fernandes D; Santos M; Pinheiro M; Duarte H; Fontes F
Nucl Med Commun; 2023 Oct; 44(10):870-875. PubMed ID: 37464878
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronidase for treating intravenous extravasations.
Few BJ
MCN Am J Matern Child Nurs; 1987; 12(1):23. PubMed ID: 3102879
[No Abstract] [Full Text] [Related]
20. [Update in the management of extravasations of cytocytostatic agent].
Conde-Estévez D; Mateu-de Antonio J
Farm Hosp; 2012; 36(1):34-42. PubMed ID: 21798785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
